Xiaoxin Cai

1.3k citations

16 papers · 1.0k indexed · h-index 14

Impact in

Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
Oncology top 5%
- Drug Transport and Resistance Mechanisms

Papers in ⓘ

Oncology 9
- Drug Transport and Resistance Mechanisms 9
Pediatrics, Perinatology and Child Health 5
- Pharmacological Effects and Toxicity Studies 5

Co-authors: Xiaoyan Chu (8 shared papers)Raymond Evers (8 shared papers)Jocelyn Yabut (4 shared papers)Grace Chan (4 shared papers)David C. Evans (3 shared papers)Regina W. Wang (3 shared papers)Thomayant Prueksaritanont (3 shared papers)Iain P. Fraser (2 shared papers)
Journals: Drug Metabolism and Disposition (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)American Journal Of Pathology (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Pharmaceutical Research (1 paper)
Partner nations: United States China United Kingdom

In The Last Decade

Xiaoxin Cai

16 papers receiving 1.0k citations

Peers

Countries citing papers authored by Xiaoxin Cai

Since Specialization

Citations

This map shows the geographic impact of Xiaoxin Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxin Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxin Cai more than expected).

Fields of papers citing papers by Xiaoxin Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxin Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxin Cai. The network helps show where Xiaoxin Cai may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaoxin Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaoxin Cai Line = papers co-authored together Xiaoxin Cai links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Pitavastatin is a more sensitive and selective organic anion‐transporting polypeptide1Bclinical probe than rosuvastatin British Journal of Clinical Pharmacology ·Thomayant Prueksaritanont, Xiaoyan Chu, Raymond Evers, Stephanie O. Klopfer, Luzelena Caro, Prajakti A. Kothare, Cynthia Dempsey, Scott Rasmussen, Robert Houle, Grace Chan, Xiaoxin Cai, Robert Valesky, Iain P. Fraser, S. Aubrey Stoch	2014	144
2	Transport of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin by Human Organic Anion Transporter 3, Organic Anion Transporting Polypeptide 4C1, and Multidrug Resistance P-glycoprotein Journal of Pharmacology and Experimental Therapeutics ·Xiaoyan Chu, Kelly Bleasby, Jocelyn Yabut, Xiaoxin Cai, Grace Chan, Michael J. Hafey, Shiyao Xu, Arthur Bergman, Matthew P. Braun, Dennis Dean, Raymond Evers	2007	143
3	Rifampin's Acute Inhibitory and Chronic Inductive Drug Interactions: Experimental and Model-Based Approaches to Drug–Drug Interaction Trial Design Clinical Pharmacology & Therapeutics ·Marc L. Reitman, Xiaoyan Chu, Xiaoxin Cai, Jocelyn Yabut, Raja Venkatasubramanian, Stefan Zajic, J.A. Stone, Ying Ding, Rose Witter, Christopher R. Gibson, Kathryn Roupe, Raymond Evers, JA Wagner, Aubrey Stoch	2010	133
4	Cytochrome P450 3A4-Mediated Bioactivation of Raloxifene: Irreversible Enzyme Inhibition and Thiol Adduct Formation Chemical Research in Toxicology ·Qing Chen, Jason S. Ngui, George A. Doss, Regina W. Wang, Xiaoxin Cai, Frank DiNinno, Timothy A. Blizzard, Milton L. Hammond, Ralph A. Stearns, David C. Evans, Thomas A. Baillie, Wei Tang	2002	110
5	Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A Clinical Pharmacology & Therapeutics ·Thomayant Prueksaritanont, DA Tatosian, Xiaoyan Chu, Radha Railkar, Raymond Evers, C.M. Chavez-Eng, Ryan Lutz, W. Zeng, Jocelyn Yabut, GH Chan, Xiaoxin Cai, AH Latham, J Hehman, Daria Stypinski, John Brejda, Changjun Zhou, Bob Thornton, Kevin P. Bateman, Iain P. Fraser, SA Stoch	2016	109
6	Characterization of Mice Lacking the Multidrug Resistance Protein Mrp2 (Abcc2) Journal of Pharmacology and Experimental Therapeutics ·Xiaoyan Chu, John R. Strauss, Michele A. Mariano, Jing Li, Deborah J. Newton, Xiaoxin Cai, Regina W. Wang, Jocelyn Yabut, Dylan P. Hartley, David C. Evans, Raymond Evers	2006	105
7	Hyperlipidemia induces meibomian gland dysfunction The Ocular Surface ·Jinghua Bu, Yang Wu, Xiaoxin Cai, Nan Jiang, M. Vimalin Jeyalatha, Jingwen Yu, Xin He, Hui He, Yuli Guo, Mingjie Zhang, Andrew J. Quantock, Zuguo Liu, Wei Li	2019	58
8	Evaluation of Cynomolgus Monkeys for the Identification of Endogenous Biomarkers for Hepatic Transporter Inhibition and as a Translatable Model to Predict Pharmacokinetic Interactions with Statins in Humans Drug Metabolism and Disposition ·Xiaoyan Chu, Shian‐Jiun Shih, Rachel Shaw, Hannes Hentze, Grace Chan, Karen Owens, Shubing Wang, Xiaoxin Cai, Deborah J. Newton, José Castro‐Perez, Gino Salituro, Jairam Palamanda, Aaron Z. Fernandis, Choon Keow Ng, Andy Liaw, Mary J. Savage, Raymond Evers	2015	56
9	In Vitro Assessment of Drug-Drug Interaction Potential of Boceprevir Associated with Drug Metabolizing Enzymes and Transporters Drug Metabolism and Disposition ·Xiaoyan Chu, Xiaoxin Cai, Donghui Cui, Cuyue Tang, Anima Ghosal, Grace Chan, Mitchell D. Green, Yuhsin Kuo, Yuexia Liang, Cheri M. Maciolek, Jairam Palamanda, Raymond Evers, Thomayant Prueksaritanont	2013	48
10	High-Fat Diet–Induced Functional and Pathologic Changes in Lacrimal Gland American Journal Of Pathology ·Xin He, Zhongyang Zhao, Shaopan Wang, Jie Kang, Minjie Zhang, Jinghua Bu, Xiaoxin Cai, Changkai Jia, Yixuan Li, Kechun Li, Peter S. Reinach, Andrew J. Quantock, Zuguo Liu, Wei Li	2020	39
11	Ectodysplasin A protein promotes corneal epithelial cell proliferation Journal of Biological Chemistry ·Sanming Li, Jing Zhou, Jinghua Bu, Ke Ning, Liying Zhang, Juan Li, Yuli Guo, Xin He, Hui He, Xiaoxin Cai, Yongxiong Chen, Peter S. Reinach, Zuguo Liu, Wei Li	2017	23
12	VALIDATION OF (-)-N-3-BENZYL-PHENOBARBITAL AS A SELECTIVE INHIBITOR OF CYP2C19 IN HUMAN LIVER MICROSOMES Drug Metabolism and Disposition ·Xiaoxin Cai, Regina W. Wang, Richard W. Edom, David C. Evans, Magang Shou, A. David Rodrigues, Wensheng Liu, Dennis Dean, Thomas A. Baillie	2004	22
13	Hyperlipidemia Affects Tight Junctions and Pump Function in the Corneal Endothelium American Journal Of Pathology ·Jinghua Bu, Jingwen Yu, Yang Wu, Xiaoxin Cai, Kechun Li, Liying Tang, Nan Jiang, M. Vimalin Jeyalatha, Minjie Zhang, Huimin Sun, Hui He, Andrew J. Quantock, Yongxiong Chen, Zuguo Liu, Wei Li	2020	17
14	Metabolism and Renal Elimination of Gaboxadol in Humans: Role of UDP-Glucuronosyltransferases and Transporters Pharmaceutical Research ·Xiaoyan Chu, Yuexia Liang, Xiaoxin Cai, Karla G. Cuevas‐Licea, Ronda Rippley, Kelem Kassahun, Magang Shou, Matthew P. Braun, George A. Doss, M. Reza Anari, Raymond Evers	2008	16
15	Therapeutic Effect of MK2 Inhibitor on Experimental Murine Dry Eye Investigative Ophthalmology & Visual Science ·Yang Wu, Jinghua Bu, Yiran Yang, Xiang Lin, Xiaoxin Cai, Caihong Huang, Xiaoxiang Zheng, Weijie Ouyang, Wei Li, Xiaobo Zhang, Zuguo Liu	2017	12
16	Pharmacovigilance insights into drug-associated venous thromboembolism International Journal of Surgery ·Xiaoxin Cai, Guoquan Chen, Haiping Wang, Xuan Wang, Congli Hu	2025	1

About Xiaoxin Cai

Xiaoxin Cai is a scholar working on Oncology, Pediatrics, Perinatology and Child Health, Pharmacology, Public Health, Environmental and Occupational Health and Ophthalmology, having authored 16 papers that have together received 1.0k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (9 papers), Pharmacological Effects and Toxicity Studies (5 papers), Ocular Surface and Contact Lens (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Glaucoma and retinal disorders (3 papers), HIV/AIDS drug development and treatment (2 papers), Pharmacovigilance and Adverse Drug Reactions (1 paper) and Mast cells and histamine (1 paper). The work is most often cited by research in Pharmacology (388 citations), Oncology (578 citations), Pediatrics, Perinatology and Child Health (340 citations), Clinical Biochemistry (46 citations) and Toxicology (23 citations). Xiaoxin Cai has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Xiaoyan Chu, Raymond Evers, Jocelyn Yabut, Grace Chan, David C. Evans, Regina W. Wang, Thomayant Prueksaritanont, Iain P. Fraser, Dennis Dean and Matthew P. Braun. Their work appears in journals such as Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics, American Journal Of Pathology, Clinical Pharmacology & Therapeutics and Pharmaceutical Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact